Form 8-K IOVANCE BIOTHERAPEUTICS, For: May 18
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Iovanace Biotherapeutics (IOVA) Has Strong Cash Cushion Even as CEO Exit Adds to Uncertainties - Mizuho
May 19, 2021 12:42 PM EDTMizuho Securities analyst Mara Goldstein weighed in on Iovanace Biotherapeutics (NASDAQ: IOVA) after the company announced that Maria Fardis, Ph.D. will resign as President and CEO of the company following today's regulatory setback.
"The commercial potential for lifileucel remains but the question... More
Iovance Biotherapeutics (IOVA) Halted on LUDP
May 19, 2021 12:01 PM EDTIovance Biotherapeutics (NASDAQ: IOVA) Halted on LUDP
Iovance Biotherapeutics (IOVA) CEO Resigns
May 19, 2021 12:01 PM EDTIovance Biotherapeutics (NASDAQ: IOVA) disclosed:
On May 18, 2021, Maria Fardis, Ph.D., the Chief Executive Officer (CEO) of Iovance Biotherapeutics, Inc. (the Company), notified the Company that she will be resigning as President, CEO and a director of the Company to pursue other opportunities. The... More
